Pharma & Biotech
Subscriber Request Series: 5 Biotechnology (biotech) and 2 Pharmaceutical (pharma) Companies on sale. Each Tuesday I cover stocks that have been requested from our channel’s YouTube subscribers. This week I covered pharmaceutical giant Merck (MRK) and the much smaller company in transition Teva Pharmaceutical (TEVA). In the biotechnology subindustry I covered AbbVie (ABBV), Biogen (BIIB), Regeneron (REGN), Gilead (GILD), and Vertex (VRTX). Even in today’s very expensive stock market, there are many healthcare stocks that are on sale. Consequently, healthcare represents a fertile field for value-oriented investors seeking good investments that simultaneously provide a margin of safety. I believe that 6 of the 7 stocks I am covering this week fit that bill. Moreover, although one stock, Vertex, looks expensive, its price has been reverting to the mean torts fair value. As a result, patient investors might keep their eye on this stock as it gets closer and closer to attractive valuation.
FAST Graphs Analyze Out Loud Video on Pharma & BioTech Stocks:
Disclosure: Long ABBV, MRK, TEVA at the time of writing.
Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as predicted. The information in this document is believed to be accurate, but under no circumstances should a person act upon the information contained within. We do not recommend that anyone act upon any investment information without first consulting an investment advisor as to the suitability of such investments for his specific situation.